IE
BCAB icon

Israel Englander’s BioAtla BCAB Stock Holding History

Israel Englander’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$292K Buy
70,616
+15,483
+28% +$65.6K ﹤0.01% 5125
2026
Q1 		$444K Buy
55,133
+39,885
+262% +$467K ﹤0.01% 4830
2025
Q4 		$433K Buy
15,248
+8,422
+123% +$330K ﹤0.01% 5041
2025
Q3 		$235K Buy
+6,826
New +$158K ﹤0.01% 5467
2025
Q2 		– Sell
-2,333
Closed -$40.5K – 5858
2025
Q1 		$40.5K Sell
2,333
-19,579
-89% -$419K ﹤0.01% 5564
2024
Q4 		$648K Sell
21,912
-31,280
-59% -$2.63M ﹤0.01% 4543
2024
Q3 		$4.68M Buy
53,192
+20,207
+61% +$1.69M ﹤0.01% 2903
2024
Q2 		$2.26M Buy
32,985
+15,512
+89% +$1.85M ﹤0.01% 3437
2024
Q1 		$3.01M Buy
17,473
+13,097
+299% +$1.63M ﹤0.01% 3360
2023
Q4 		$538K Buy
4,376
+2,519
+136% +$218K ﹤0.01% 4598
2023
Q3 		$158K Sell
1,857
-3,845
-67% -$490K ﹤0.01% 5208
2023
Q2 		$855K Buy
5,702
+2,028
+55% +$349K ﹤0.01% 4165
2023
Q1 		$492K Buy
3,674
+1,633
+80% +$294K ﹤0.01% 4612
2022
Q4 		$842K Buy
2,041
+1,415
+226% +$587K ﹤0.01% 4330
2022
Q3 		$241K Sell
626
-2,920
-82% -$956K ﹤0.01% 5529
2022
Q2 		$505K Sell
3,546
-4,911
-58% -$782K ﹤0.01% 4943
2022
Q1 		$2.11M Buy
8,457
+4,461
+112% +$1.87M ﹤0.01% 3823
2021
Q4 		$3.92M Buy
3,996
+2,745
+219% +$3.51M ﹤0.01% 3142
2021
Q3 		$1.84M Buy
+1,251
New +$2.44M ﹤0.01% 4024
2021
Q2 		– Sell
-565
Closed -$1.44M – 6523
2021
Q1 		$1.44M Sell
565
-5,978
-91% -$15.3M ﹤0.01% 3846
2020
Q4 		$11.1M Buy
+6,543
New +$10.9M 0.01% 1612

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Israel Englander's BCAB Position: Q2 2026 in Review

Israel Englander increased its BioAtla (BCAB) stake by 28% in Q2 2026, buying an estimated $65.6K and bringing the position to 70,616 shares worth $292K. The position accounts for ﹤0.01% of the portfolio, ranked #5125.

Israel Englander first reported a position in BCAB in Q4 2020 and has held it in 21 quarters since. The position peaked at $11.1M in Q4 2020. 21 funds tracked by Wall St. Rank hold BCAB as of Q2 2026.

  • Israel Englander held 70,616 shares of BioAtla worth $292K as of Q2 2026.
  • Israel Englander bought 15,483 BioAtla shares in Q2 2026, an estimated $65.6K.
  • BioAtla made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #5125 holding.
  • Israel Englander first reported a position in BioAtla in Q4 2020 and has held it in 21 quarters since.
  • Israel Englander's BioAtla position peaked at $11.1M in Q4 2020.
  • 21 funds tracked by Wall St. Rank held BioAtla as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.